InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,232.40
(
0.00%
)
Dow Jones
39,872.99
(
0.17%
)
Brent Oil
81.95
(
-0.60%
)
Bitcoin
70,040.04
(
-0.13%
)
Post# of 251888
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: None

Monday, 04/16/2012 8:54:07 PM

Monday, April 16, 2012 8:54:07 PM

Post# of 251888
Biosimilar infliximab (Remicade) under EMA Review

[Celltrion is partnered with HSP for this product]

http://www.biosimilarnews.com/biosimilar-remicade-under-review-in-eu
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up